Functionally, CLCN3 is considered to be instrumental and indispensable in the control of inflammation of adipose tissue and obesity in mammals, and therefore, it has been useful in the therapeutic treatment of type 2 diabetic patients and obesity [15]. Here, CLCN3 is linked to obesity due to melanocortin 4 receptor deficiency.